ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
STANFORD HOSPITAL AND CLINICS
ADULT HYPERTENSION PROTOCOL
STANFORD COORDINATED CARE
___________________________________________________________________
I.
PURPOSE
To establish guidelines for the monitoring of antihypertensive therapy in adult patients and
to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy
resident.
SUPPORTIVE INFORMATION
Goal of Therapy
The ultimate goal of antihypertensive therapy is the reduction of cardiovascular and renal
morbidity and mortality. Since most persons with hypertension, especially those age >50
years, will reach the DBP goal once SBP is at goal, the primary focus should be on achieving
the SBP goal. Treating SBP and DBP to targets that are 180 systolic
on 3 BP meds
Add another second- or third-line drug and increase doses of other
agents. If other agent(s) at or above mid-dose, add a combination
of 2 additional drugs.
Address reasons for non-adherence, enlisting family members and
other social support, use electronic medication monitor to provide
feedback and reinforcement.
Consult patient¡¯s physician
Adult Hypertension Protocol ¨C Stanford Coordinated Care
Page 4
STANFORD HOSPITAL AND CLINICS
ADULT HYPERTENSION PROTOCOL
STANFORD COORDINATED CARE
___________________________________________________________________
Table 3: First Line Drug Choices
Diagnosis
Uncomplicated Hypertension
Drug Class
Thiazide diuretic (maximum dose 25 mg)
Diabetes mellitus with or without proteinuria
ACE inhibitor or ARB
Isolated systolic hypertension (elderly)
Diuretic
CCB (long-acting dihydropyridine)
ACE inhibitor
Beta-blocker
Diuretic
ARB
Aldosterone antagonist
Diuretic
ACE inhibitor/ARB
Beta-blocker
Long-acting CCB
ACE inhibitor
Beta-blocker
Aldosterone antagonist
Diuretic
ACE inhibitor
Short-acting ACE inhibitor
ARB
Heart failure: left ventricular dysfunction
High risk CHD
Post MI
Stroke Prevention
Chronic kidney disease
*See individual drug protocols for exclusion criteria and algorithm.
Table 4: Drugs the May Have Unfavorable Effects on Comorbid Conditions
Condition
Angiodema
Bronchospastic disease
Gout
Heart block (second or third degree)
Hyponatremia
Potassium >5 mEq/L before treatment
Pregnancy or those likely to become pregnant
Drug Therapy to Avoid
ACEI
Beta-blocker
Thiazide diuretic
Beta-blocker, CCB (non-DHP)
Thiazide diuretic
Potassium sparing diuretic, aldosterone antagonist
ACEI, ARB
Adult Hypertension Protocol ¨C Stanford Coordinated Care
Page 5
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- new horizons in pulmonary arterial hypertension therapies
- new drugs procedures and devices for hypertension
- management of preoperative hypertension university of rochester
- current knowledge about the new drug firibastat in arterial hypertension
- new hypertension guidelines piedmont
- new drug targets for hypertension a literature review researchgate
- new drugs procedures and devices for hypertension the lancet
- hypertension medication treatment protocol american medical association
- e 12 principles for clinical evaluation of new antihypertensive drugs
- new drugs for hypertension what do they offer
Related searches
- stanford health care tax id
- adult day care resume samples
- adult day care licensing requirements
- stanford health care hospital
- stanford health care stanford medicine
- adult critical care drip
- adult day care start up cost
- adult day care business
- adult day care plan template
- adult day care rates
- stanford health care logo
- hypertension care plan template